Bioscience Animal Health Public Company Limited
2.34
THB
+0.02
(+0.86%)
ISIN
THA776010003
Return %
Stock
S&P 500
1Y
-5.65
14.20
3Y
-53.20
81.12
5Y
- -
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Poramase Khamphak
- Full Time Employees
- 120
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- BIS Tower Pakkret NU Thailand 11120
- IPO Date
- May 5, 2022
- Website
- bis-group.com
- Similar Companies
- Business
- Bioscience Animal Health Public Company Limited (Ticker: BIS.BK) operates as a manufacturer, importer, and distributor of pharmaceutical supplies, medical devices, equipment, and related products tailored for livestock and companion animals. Its core product portfolio includes antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and proprietary series such as Bismix B and SD, which cater to both livestock and pet health markets. The company also provides trading services and exports its products. Founded in 2004, Bioscience Animal Health is headquartered in Nonthaburi, Thailand, and functions as a prominent player in the animal pharmaceutical, feed additive, and raw material markets in Thailand. In recent developments within the last 1-2 years, the company has pursued strategic partnerships that enhance its position in diagnostics and animal health services, leading to increased investor confidence and sector growth prospects. It has also seen expansion in product offerings aligned with its business tagline "BEYOND ANIMAL WELLBEING," focusing on improving the quality of animal life through quality veterinary-selected products. The company remains concentrated on advancing its manufacturing capabilities and distribution outreach, bolstered by consistent revenue growth in key segments such as diagnostics and nutrition products. Bioscience Animal Health serves a broad customer base within the animal health industry, including farmers, veterinarians, and pet owners, operating primarily in Thailand with an export footprint. The company’s strategic focus includes continual enhancement of animal wellbeing through innovation and professional selection, positioning it within the animal healthcare and pharmaceutical sectors, particularly in Southeast Asia. Subsidiary activities include ventures in pet animal data and insurance services, reflecting an expanded scope into pet care lifecycle management. Overall, Bioscience Animal Health Public Company Limited is a well-established entity in animal healthcare, noted for its comprehensive product range, strategic partnerships, and active market presence in Thailand and beyond since its inception in 2004.